Recently we reported that inhibition of arachidonate-5-lipoxygenase (5-Lox) by gene-targeting or by chemical inhibitors down-regulates expression and function of c-Myc selectively in cancer cells, but spares c-Myc activity in normal, non-cancer cells17,18. Here, MYC is linked to cancer.